Dominant Intermediate B Charcot-Marie-Tooth Disease

Also Known As:

Charcot-Marie-Tooth Disease, Dominant Intermediate B; CMTDI1; CMTDIB; Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2m; Charcot-Marie-Tooth Disease, Axonal, Type 2m; Charcot-Marie-Tooth Disease, Dominant Intermediate B, With Neutropenia; Charcot-Marie-Tooth Neuropathy, Axonal, Type 2m; Charcot-Marie-Tooth Neuropathy, Dominant Intermediate B; Cmt2m

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Congenital Structural Myopathies (Centronuclear Myopathy)

Experts

1.	Blasevich, Flavia: 1 article (02/2016)
2.	Bragato, Cinzia: 1 article (02/2016)
3.	Cotelli, Franco: 1 article (02/2016)
4.	Gaudenzi, Germano: 1 article (02/2016)
5.	Giunta, Michele: 1 article (02/2016)
6.	Maggi, Lorenzo: 1 article (02/2016)
7.	Mora, Marina: 1 article (02/2016)
8.	Pavesi, Giulio: 1 article (02/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Dominant Intermediate B Charcot-Marie-Tooth Disease:

1.	Dynamin IIIBA 02/04/2016 - "Mutations in the dynamin-2 gene (DNM2) cause autosomal dominant centronuclear myopathy (CNM) and dominant intermediate Charcot-Marie-Tooth (CMT) neuropathy type B (CMTDIB). "